RecruitingNot ApplicableNCT06907667

Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure

Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure - CHRONOVAX 2


Sponsor

Centre Hospitalier Universitaire de Nice

Enrollment

735 participants

Start Date

Sep 3, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Immune response to influenza vaccine in patients with chronic renal insufficiency.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether the timing of the flu shot (morning versus afternoon) affects how well the immune system responds in people with chronic kidney disease, those on dialysis, or kidney transplant recipients. **You may be eligible if...** - You are 18 or older - You have chronic kidney disease (stage 4 or 5), are on dialysis, or have had a kidney transplant - You are due for your flu vaccination this season **You may NOT be eligible if...** - You have a known allergy to the flu vaccine or eggs - You have already received a flu shot this season - You currently have an active infection or acute illness - You are receiving certain immune-suppressing treatments (such as anti-rejection medications started within the last 3–6 months) - You are receiving treatments that could affect blood antibody levels Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERVaccine injection

Injection of the vaccine in chronic renal insufficiency patients.


Locations(1)

CHU Nice - Hôpital Pasteur 2

Nice, Alpes-Maritimes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06907667


Related Trials